Login / Signup

Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety.

Catherine G DeringtonJordan B KingThomas DelateSheila R BottsMiranda KroehlDavid P KaoKaty E Trinkley
Published in: PloS one (2020)
Adjusted models do not support improved effectiveness or safety of BID lisinopril and losartan.
Keyphrases
  • angiotensin ii
  • physical activity
  • blood pressure
  • randomized controlled trial
  • systematic review
  • arterial hypertension